GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Kanabo Group PLC (LSE:KNB) » Definitions » Insider Ownership

Kanabo Group (LSE:KNB) Insider Ownership : 24.32 % (As of Sep. 22, 2024)


View and export this data going back to 2017. Start your Free Trial

What is Kanabo Group Insider Ownership?

Insider ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Kanabo Group's insider ownership is 24.32%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Kanabo Group's Institutional Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Kanabo Group's Float Percentage Of Total Shares Outstanding is 0.00%.


Kanabo Group Insider Ownership Historical Data

The historical data trend for Kanabo Group's Insider Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kanabo Group Insider Ownership Chart

Kanabo Group Historical Data

The historical data trend for Kanabo Group can be seen below:

2023-11-30 2023-12-31 2024-01-31 2024-02-29 2024-03-31 2024-04-30 2024-05-31 2024-06-30 2024-07-31 2024-08-31
Insider Ownership 21.48 21.48 21.48 21.48 21.48 21.48 24.29 24.29 24.29 24.32

Kanabo Group Insider Ownership Calculation

The percentage of shares that are owned by company insiders relative to the total shares outstanding.


Kanabo Group Business Description

Traded in Other Exchanges
Address
137-139 Brent Street, Churchill House, London, GBR, NW4 4DJ
Kanabo Group PLC is a research and development company engaged in selling a range of THC-Free retail CBD products in the markets and it is in the process of developing medical cannabis products. Its reportable segments include Primary Care and Secondary Care. The Primary Care segment includes Tele pharma services provided by GPS and The Secondary Care segment includes the development and distribution of cannabis-derived medical and wellness products. Geographically company has a presence in the United Kingdom, Israel, and others.

Kanabo Group Headlines

No Headlines